Wednesday, June 22, 2016
- 12:00pm-1:30pm
-
The role of depression in suicidal ideation in a sample of patients with Parkinson’s disease
Parkinson's disease: Psychiatric manifestations · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
The role of neuroinflammation in the development of Parkinson’s disease dementia
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
The role of striatal dopaminergic terminals in early de novo PD patients with speech impairment
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
The role of the frontal lobe in complex walking among healthy older adults and patients with Parkinson’s disease: An fNIRS study
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
The scale for assessment and rating of ataxia in early onset ataxia; always a reliable biomarker?
Ataxia · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
The spectrum of abnormal movements and predictors of outcome in anti-NMDA receptor encephalitis in Thai patients
Phenomenology and clinical assessment of movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
The value of multi-slice computed tomography angiography in diagnosis of intracranial circulation in patients with vascular parkinsonism
Neuroimaging (non-PD) · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
THK-5351 tau-tracer uptake in patients with clinically diagnosed progressive supranuclear palsy
Neuroimaging (non-PD) · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Three-dimensional cytoarchitecture of the basal ganglia: Clinical applications of a computational pipeline for histology to MRI registration
Neuroimaging (non-PD) · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
TMS-EEG markers of inhibitory deficits in Huntington’s disease
Neurophysiology (non-PD) · Exhibit Hall located in Hall B, Level 2